StockData
Regencell Bioscience Holdings Ltd logo

Regencell Bioscience Holdings Ltd (RGC) stock

RGCNasdaqMedicinal Chemicals & Botanical Products
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30
$4.55−0.17 (-3.60%)

Close on Nov 17, 2026Market cap $2.26BP/E –Yield –

Regencell Bioscience total assets

Total assets on the balance sheet at the end of each period.

Regencell Bioscience's total assets was $14.73M at Jun 30, 2026. For fiscal 2026 it was $14.73M, up 155.9% from the year before. The highest annual figure on record is $18.02M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$14.73M+155.9%
FY2025Jun 30, 2025$5.76M-31.8%
FY2024Jun 30, 2024$8.44M-33.1%
FY2023Jun 30, 2023$12.62M-30.0%
FY2022Jun 30, 2022$18.02M+5197.6%
FY2021Jun 30, 2021$340.13K-33.8%
FY2020Jun 30, 2020$514.02K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$14.73M+16.7%
Q2 FY2026CQ4 2025Dec 31, 2025$3.01M-83.3%
Q4 FY2025CQ2 2025Jun 30, 2025$5.76M+1592.2%
Q4 FY2024CQ2 2024Jun 30, 2024$8.44M+1541.6%
Q4 FY2023CQ2 2023Jun 30, 2023$12.62M–
Q4 FY2022CQ2 2022Jun 30, 2022$18.02M–
Q4 FY2021CQ2 2021Jun 30, 2021$340.13K–
Q4 FY2020CQ2 2020Jun 30, 2020$514.02K–

More Regencell Bioscience figures

See a number that looks wrong?